[1] MUKHERJEE P, KARAM A, CHAKRABORTY A K, et al. Identification of a novel cluster of PCV2 isolates from Meghalaya, India indicates possible recombination along with changes in capsid protein[J]. Infect Genet Evol, 2019, 71:7-15. [2] CHEN S, LI X, ZHANG L Y, et al. Phylogenetic and structural analysis of porcine circovirus type 2 from 2016 to 2021 in Jilin Province, China[J]. Microorganisms, 2023, 11(4):983. [3] 莫荣君. 猪圆环病毒病的流行病学分析及防控措施[J]. 畜禽业, 2020, 31(8):91-92. MO R J. Epidemiological analysis and prevention measures of porcine circovirus disease[J]. Livestock and Poultry Industry, 2020, 31(8):91-92. (in Chinese) [4] 代 科. 副猪嗜血杆菌PotD蛋白的毒力相关性及其通过TLR4诱导先天性免疫的通路研究[D]. 雅安:四川农业大学, 2020. DAI K. Studies on virulence regulation and innate immunity pathway of Glaesserella parasuis polyamine transporter PotD[D]. Yaan:Sichuan Agricultural University, 2020. (in Chinese) [5] 陈 娟. 副猪嗜血杆菌贵州株的分离鉴定及生物学特性研究[D]. 贵阳:贵州大学, 2020. CHEN J. Isolation, identification and biological characteristics research of Haemophilus parasuis Guizhou strain[D]. Guiyang:Guizhou University, 2020. (in Chinese) [6] 何绿琴, 闫雪锋, 文心田, 等. 副猪嗜血杆菌qseB、qseC双基因缺失株的构建及生物学特性[D]. 畜牧兽医学报, 2022, 53(2):529-537. HE L Q, YAN X F, WEN X T, et al. Construction and biological characteristic of Glaesserella parasuis strain with qseB, qseC double gene deletion [D]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(2):529-537. (in Chinese) [7] 吕茂杰. 猪圆环病毒2型-猪肺炎支原体-副猪嗜血杆菌三联灭活疫苗的研制[D]. 长春:吉林大学, 2022. LV M J. Development of the triple inactivated vaccine against porcine circovirus type 2, Mycoplasma hyopneumoniae and Haemophilus parasuis[D]. Changchun:Jilin University, 2022. (in Chinese) [8] BATAH A M, AHMAD T A. The development of ghost vaccines trials[J]. Expert Rev Vaccines, 2020, 19(6):549-562. [9] SALEH N, MAHMOUD H E, ELTAHER H, et al. Prodigiosin-functionalized probiotic ghosts as a bioinspired combination against colorectal cancer cells[J]. Probiotics Antimicrob Proteins, 2023, 15(5):1271-1286. [10] HAJAM I A, DAR P A, WON G, et al. Bacterial ghosts as adjuvants:mechanisms and potentia[J]. Vet Res, 2017, 48(1):37. [11] SOLEYMANI S, TAVASSOLI A, HASHEMI TABAR G, et al. Design, development, and evaluation of the efficacy of a nucleic acid-free version of a bacterial ghost candidate vaccine against avian pathogenic E. coli (APEC) O78:K80 serotype[J]. Vet Res, 2020, 51(1):144. [12] HARISA G I, SHERIF A Y, YOUSSOF A M E, et al. Bacteriosomes as a promising tool in biomedical applications:immunotherapy and drug delivery[J]. AAPS PharmSciTech, 2020, 21(5):168. [13] WEN J, YANG Y, ZHAO G Y, et al. Salmonella typhi Ty21a bacterial ghost vector augments HIV-1 gp140 DNA vaccine-induced peripheral and mucosal antibody responses via TLR4 pathway[J]. Vaccine, 2012, 30(39):5733-5739. [14] VINOD N, NOH H B, OH S, et al. A Salmonella typhimurium ghost vaccine induces cytokine expression in vitro and immune responses in vivo and protects rats against homologous and heterologous challenges[J]. PLoS One, 2017, 12(9):e0185488. [15] LI S Y, WANG D, GUO C Y, et al. Study on preparation of a Streptococcus suis ghost vaccine[J]. Microb Pathog, 2021, 154:104865. [16] 王丹丹, 倪艳秀, 祝昊丹, 等. 应用NaOH制备胸膜肺炎放线杆菌菌影方法的建立[J]. 中国兽医科学, 2017, 38(8):999-1004. WANG D D, NI Y X, ZHU H D, et al. Establishment of a novel preparation method for Actinobacillus pleuropneumoniae ghost by sodium hydroxide[J]. Chinese Veterinary Science, 2017, 38(8):999-1004. (in Chinese) [17] JI S, MOON E S, NOH H B, et al. Protective immunity against Listeria monocytogenes in rats, provided by HCl- and NaOH-induced Listeria monocytogenes bacterial ghosts (LMGs) as vaccine candidates[J]. Int J Mol Sci, 2022, 23(4):1946. [18] VINOD N, OH S, PARK H J, et al. Generation of a novel Staphylococcus aureus ghost vaccine and examination of its immunogenicity against virulent challenge in rats[J]. Infect Immun, 2015, 83(7):2957-2965. [19] PORTER K R, RAVIPRAKASH K. DNA vaccine delivery and improved immunogenicity[J]. Curr Issues Mol Biol, 2017, 22:129-138. [20] SYLLA S, CONG Y L, SUN Y X, et al. Protective immunity conferred by porcine circovirus 2 ORF2-based DNA vaccine in mice[J]. Microbiol Immunol, 2014, 58(7):398-408. [21] WU X Y, JU X R, DU L H, et al. Production of bacterial ghosts from gram-positive pathogen Listeria monocytogenes[J]. Foodborne Pathog Dis, 2017, 14(1):1-7. [22] WANG Z H, ZHAO Q, WEI H L, et al. Prevalence and seroepidemiology of Haemophilus parasuis in Sichuan province, China[J]. PeerJ, 2017, 5:e3379. [23] FU S L, ZHANG M M, XU J, et al. Immunogenicity and protective efficacy of recombinant Haemophilus parasuis SH0165 putative outer membrane proteins[J]. Vaccine, 2013, 31(2):347-353. [24] YUAN F Y, FU S L, HU J, et al. Evaluation of recombinant proteins of Haemophilus parasuis strain SH0165 as vaccine candidates in a mouse model[J]. Res Vet Sci, 2012, 93(1):51-56. [25] 周 鹏. 鹦鹉热衣原体MOMP、MIP重组核酸菌影疫苗的免疫保护作用[D]. 衡阳:南华大学, 2018. ZHOU P. Immunoprotective effects of recombinant E. coli ghosts expressing Chlamydia psittaci MOMP and MIP[D]. Hengyang:University of South China, 2018. (in Chinese) [26] CHARERNTANTANAKUL W. Adjuvants for swine vaccines:mechanisms of actions and adjuvant effects[J]. Vaccine, 2020, 38(43):6659-6681. [27] 周伃欣, 何久香, 全纹萱, 等. 登革病毒多价DNA疫苗构建及免疫保护效果验证[J]. 免疫学杂志, 2023, 39(1):70-77. ZHOU Y X, HE J X, QUAN W X, et al. Construction and immune protection verification of dengue virus multivalent DNA vaccine[J]. Immunological Journal, 2023, 39(1):70-77. (in Chinese) |